Skip to main content
OpenTrials
Completed

NCT Number: NCT05030402

Efficacy of Maitland Mobilization in Shoulder Pathology

The shoulder is a mobile structure which generates a lot of pathologies. One of them is rotator cuff tendinosis. On the other hand, it has been investigated that Maitland is effective for reducing pain and for mobility in the cervical and lumbar spine and in joints such as the knee and ankle, however, there are few studies that confirm that it is effective in shoulder pathologies.So here the investigatprs want to study the effectiveness of Maitland as an adjunctive treatment for shoulder pathologies, comparing it with conventional physiotherapy treatment, in relation to the reduction of pain and increased mobility. For that the investigators have a randomized clinical trial with two group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tendinosis Muscular Diseases Musculoskeletal Diseases Tendinopathy Tendon Injuries Wounds and Injuries

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

GRUPO ICOT Policlínico Las Palmas.

Las Palmas de Gran Canaria, Las Palmas, 35006, Spain

About this study

Group 1 receives tens, SW, conventional physiotherapy and exercises as treatment. Group 2 receives tens, SW, Mailtland, and exercises. An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have a shoulder pathology.
  • Have a restriction at least of two ranges of movement of the shoulder.
  • Sign the consent before starting the study.

Exclusion criteria

  • Patients with a history of shoulder or neck surgery.
  • Patients with neurological damage such as stroke or disease of Parkinson's, as well as those with rheumatism, osteoporosis, surgical fixation, or malignant tumors.
  • Have a radiating pain in shoulder from a cervical injury.
  • Pregnant patients.
  • Patients who do not sign the consent before starting the study.

Treatment and study plan

Maitland

Procedure

An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

Tens, exercise, SW

Procedure

An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

Conventional physiotherapy

Procedure

An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

Primary outcomes

  1. Change of Range of Motion (ROM)

    Time frame: Baseline and 1, 5, and 7 weeks after treatment

    Active ROM of the affected shoulder is measured using a Mechanic Analysis to assess range of motion. These measurements included abduction, flexion, internal rotation, and external rotation.

  2. Change of Visual Analog Scale (VAS)

    Time frame: Baseline and 1, 5, and 7 weeks after treatment

    Visual analogue score (VAS) was done at rest and at shoulder movement. VAS was explained to the patients during assessment as 0 equal no pain and 10 equal worst imaginable pain.

  3. Change of Disabilities of the Arm, Shoulder and Hand (DASH)

    Time frame: Baseline and 1, 5, and 7 weeks after treatment

    Disabilities of the Arm, Shoulder and Hand (DASH) was filled by patient during assessment as 0 equal better functionality and 100 equal worst functionality

Secondary outcomes

  1. Change of American shoulder and elbow Surgeons" (ASES)

    Time frame: Baseline and 1, 5, and 7 weeks after treatment

    Disabilities of the Arm, Shoulder and Hand (DASH) was filled by patient during assessment as 0 equal worst functionality and 100 is equal better functionality

  2. Change of 36-Item Health Survey (SF-36)

    Time frame: Baseline and 1, 5, and 7 weeks after treatment

    Health Survey (SF-36) was filled by patient during assessment as 0 equal worst health and 100 is equal better health

Sponsors and collaborators

Lead sponsor

University of Las Palmas de Gran Canaria

Other

Registry information

Official study title

Effec of Maitland in Shoulder Pathology

Important dates

Study start
2020
Primary completion
2021
Study completion
2022
First posted
Sep 1, 2021
Registry last updated
Nov 30, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.